obesity
Give weight-loss jabs to obese children, says top doctor
Health
Obese children should be offered weight-loss jabs to save them from a lifetime of problems, one of the world’s most senior doctors ...
New Systematic Review Unveils the Best Way To Lose Weight
Health
Systematic reviews from 2020 to 2024 indicate that bariatric surgery provides the most sustained and substantial weight loss compared to other treatments, ...
Brain Chemistry Sheds Light on Overeating and Memory
Health
Summary: Fruit flies use the neurotransmitter octopamine to decide whether food memories are stored long-term or short-term. This process, influenced by energy ...
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds
Health
Topline Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could also help ...
Groundbreaking New Weight Loss Drug Is More Effective Than Current Treatments
Health
By University of Copenhagen – The Faculty of Health and Medical Sciences May 19, 2024 Associate Professor Christoffer Clemmensen from the University ...
GLP-1 and NMDA Targeted Weight-Loss Drug Shows Promise
Health
Summary: Researchers have developed a novel weight-loss drug that combines GLP-1 with molecules targeting NMDA receptors in the brain. This “Trojan Horse” ...
High BMI Linked to Weak Smell-Eating Circuit in Brain
Health
Summary: A new study reveals a novel brain circuit linking the sense of smell and eating behavior. The weaker the connection between ...
Obesity drug slashes risk of heart attack or stroke ‘regardless of weight lost’
Trending
A five-year trial investigated whether semaglutide, a drug currently sold under the brand names Ozempic, Wegovy and Rybelsus, could reduce the risk ...
How to keep off the pounds after stopping weight-loss jabs
Health
Normally, the dose is gradually increased as patients get used to the treatment. But the study of 2,246 Danes, with an average ...
Nearly half of all cancer cases are linked to obesity
Health
The study led by Lund University in Malmo, Sweden, involved 4.1 million participants who were monitored for about 40 years, with close ...
